HMGB1 and neoplasm: On one hand, it can induce immunogenic cell death (ICD) in tumor cells, releasing DAMPs such as ATP, HMGB1, and calreticulin, which promote dendritic cell (DC) maturation and T cell activation, thereby enhancing anti-tumor immune responses [56].